刘航, 夏丽洁, 李金耀, 张英. 隐丹参酮对乳腺癌他莫昔芬耐药细胞的生长抑制作用与机制研究J. 药学学报, 2022, 57(9): 2751-2758. DOI: 10.16438/j.0513-4870.2022-0348
引用本文: 刘航, 夏丽洁, 李金耀, 张英. 隐丹参酮对乳腺癌他莫昔芬耐药细胞的生长抑制作用与机制研究J. 药学学报, 2022, 57(9): 2751-2758. DOI: 10.16438/j.0513-4870.2022-0348
LIU Hang, XIA Li-jie, LI Jin-yao, ZHANG Ying. Inhibitory effects and mechanisms of cryptotanshinone on the growth of tamoxifen resistant breast cancer cellsJ. Acta Pharmaceutica Sinica, 2022, 57(9): 2751-2758. DOI: 10.16438/j.0513-4870.2022-0348
Citation: LIU Hang, XIA Li-jie, LI Jin-yao, ZHANG Ying. Inhibitory effects and mechanisms of cryptotanshinone on the growth of tamoxifen resistant breast cancer cellsJ. Acta Pharmaceutica Sinica, 2022, 57(9): 2751-2758. DOI: 10.16438/j.0513-4870.2022-0348

隐丹参酮对乳腺癌他莫昔芬耐药细胞的生长抑制作用与机制研究

Inhibitory effects and mechanisms of cryptotanshinone on the growth of tamoxifen resistant breast cancer cells

  • 摘要: 本研究探讨了隐丹参酮(cryptotanshinone, CPT) 对乳腺癌他莫昔芬耐药细胞MCF7-TAMR的抑制作用及机制。采用MTT法检测CPT对MCF7-TAMR细胞的生长抑制作用, 发现CPT剂量与时间依赖性抑制MCF7-TAMR细胞的生长, 24 h半数抑制浓度(IC50) 为15.14 ± 2.82 μmol·L-1。CPT可阻滞细胞周期于G0/G1期, 并通过上调细胞内活性氧(reactive oxygen species, ROS) 水平促进细胞凋亡。Transwell结果显示CPT对MCF7-TAMR细胞的迁移有显著抑制作用。此外, CPT降低了MCF7-TAMR细胞来源微球体中CD24-/lowCD44+细胞群。Western blot结果证明, CPT有效抑制雌激素受体-α (estrogen receptor α, ER-α) 磷酸化, 抑制磷酸肌醇3-激酶(phosphatidylinositol 3-kinase, PI3K-p85) 与丝氨酸-苏氨酸激酶(serine-threonine protein kinase, Akt) 蛋白的表达, 同时降低了多重药物转运蛋白ABCG2 (ATP-binding cassette superfamily G member 2) 的表达。本研究结果表明, CPT通过诱导细胞凋亡, 引起细胞周期阻滞, 抑制细胞迁移、ER-α磷酸化及PI3K/Akt信号通路, 降低CD24-/lowCD44+细胞群数量及ABCG2的表达, 并可克服细胞耐药性。

     

    Abstract: This study investigated the inhibitory effect and mechanisms of cryptotanshinone (CPT) on tamoxifen resistant cell MCF7-TAMR. The inhibitory effect of CPT on the viability of MCF7-TAMR cells was evaluated using the MTT assay. We found that CPT significantly inhibited the growth of MCF7-TAMR cells in a dose- and time-dependent manner. The half inhibitory concentration (IC50) is 15.14 ± 2.82 μmol·L-1 at 24 h. CPT induced cell cycle arrest of MCF7-TAMR cells at G0/G1 phase, and promoted apoptosis of MCF7-TAMR cells by upregulating intracellular levels of reactive oxygen species (ROS). Transwell results showed that CPT significantly inhibited the migration of MCF7-TAMR cells. Furthermore, CPT decreased the CD24-/lowCD44+ cell population in MCF7-TAMR cell-derived microspheres. Western blot results showed that CPT effectively inhibited the phosphorylation of estrogen receptor α (ER-α), and reduced the expression of phosphatidylinositol 3-kinase (PI3K-p85), serine-threonine protein kinase (Akt) and multidrug transporter ATP-binding cassette superfamily G member 2 (ABCG2). These results showed that CPT can induce cell apoptosis, cause cell cycle arrest, inhibit cell migration and inhibit ER-α phosphorylation, inhibit PI3K/Akt signaling pathway, reduce the number of CD24-/lowCD44+ cells and the expression of ABCG2, overcome cell drug resistance.

     

/

返回文章
返回